Registration
CHAMBER HILL STRATEGIES for OS THERAPIES
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
cancer immunotherapy and antibody treatment; osteosarcoma
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL New | Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Rep. John Thune (R-SD) |
| SHAWN FRIESEN New | Legislative Director, Rep. Mac Collins (R-GA)); Legislative Assistant, Rep. Tom Ewing (IL-15); Clerk, House Judiciary Committee |
| JENNIFER HOLLAND New | Scheduler, Rep. Mary Kaptur (OH-09); Operations Director, Rep. Donald Norcross (NJ-01); Scheduler, Rep. Debbie Dingell (MI-06) |
Health Issues HCR
cancer immunotherapy and antibody treatment; osteosarcoma
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL New | Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Rep. John Thune (R-SD) |
| SHAWN FRIESEN New | Legislative Director, Rep. Mac Collins (R-GA)); Legislative Assistant, Rep. Tom Ewing (IL-15); Clerk, House Judiciary Committee |
| JENNIFER HOLLAND New | Scheduler, Rep. Mary Kaptur (OH-09); Operations Director, Rep. Donald Norcross (NJ-01); Scheduler, Rep. Debbie Dingell (MI-06) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.